PHIO PHARMACEUTICALS CORP. Debt Instrument, Convertible, Conversion Price
PHIO PHARMACEUTICALS CORP. (PHIO) had Debt Instrument, Convertible, Conversion Price of $1000.00 per share as of 2011-09-24, per its 10-K filed 2013-03-29.
Discontinued › Notes
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2013-03-29
- 2011-09-24: Debt Instrument, Convertible, Conversion Price $1000.00.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2011-09-24 | $1000.00 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |